There were no significant differences of either CD4+CD3+ or CD8+CD3+ T cell percentage within CD3+ T cells in IHLs between non-tumor site and tumor site (P>0.05, Student t test, Figures S1C, D). The gene discussed is CD4; the disease is neoplasm.